Abstract:Background: Multiple sclerosis (MS) is an immune-mediated central nervous system disease characterized by inflammation, demyelination and axonal degeneration. The pathology of MS suggests an autoimmune cause involving cellular and humoral components of the immune system. Active MS lesions are characterized by T-cell and macrophage infiltration and the presence of immune mediators, including adhesion molecules, chemokines, and cytokines. Cytokines are proven mediators of immunological process in MS. The aim of this study was to delineate the serum cytokine profile in patients with MS and the controls and to determine in different clinical forms of MS. Methods: This study involved 62 consecutive MS patients--28 patients with progressive MS and 34 patients with relapsing-remitting MS (RRMS). The control group consisted of 18, age and sex matched, non-immunological, neurological patients. The patients were evaluated using the Expanded Disability Status Scale (EDSS) and magnetic resonance imaging (MRI) with gadolinium. Serum samples for cytokine measurements were collected on admission. Plasma levels of proinflammatory T-helper (TH)1 (interferon (IFN)-γ) cytokines, peripheral monokines (IL-1beta, IL-6, TNF-alpha) and anti-inflammatory or down-regulatory TH2 cytokines (IL-4, IL-10) were determined by an enzyme-linked immunosorbent assay (ELISA) method. Results: All patients with MS had significantly higher cytokine (IFN-γ, IL-1β, IL-6, TNF-α, IL-4, IL-10) concentrations compared with controls (p < 0.001). Increased IL1beta, IFN-γ (p=0.032 and 0.041, respectively) and decreased IL-4, IL-10 (p=0.038 and 0.02, respectively) levels were found in progressive MS compared with RRMS. Patients with progressive MS with disease progression presented higher IL-1beta, TNF-alpha, IFN-γ and IL-10 levels than those without disease progression (p < 0.05). There was a significant inverse correlation between IL-10 levels and EDSS score in patients with progressive MS (R = 0.43, p < 0.05). Conclusion: Profiling cytokines in multiple sclerosis may help to identify mechanisms involved in the pathogenesis of the disease, and, potentially, lead to new therapies directed at cytokines or their receptors. The level of IL-10 can serve as an additional diagnostic criterion for assessing the disability in patients with progressive MS.

Progression predictors of clinically isolated syndrome to multiple sclerosis: A prospective study in China

Application of the 2017 McDonald Criteria in a Chinese Population with Clinically Isolated Syndrome.

Analysis of Factors Correlated with Spinal Clinically Isolated Syndrome Conversion to Multiple Sclerosis.

IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis

Prognostic relevance of the C‐X‐C motif chemokine ligand 13 and interleukin‐8 in predicting the transition from clinically isolated syndrome to multiple sclerosis

Multiple Sclerosis: Clinical Features and MRI Findings in Northern China

Investigation of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor concentrations in serum and cerebral spinal fluid in patients of clinically isolated syndrome

IgG index for multiple sclerosis diagnosis: old test do the trick

Higher Health Care Use Before a Clinically Isolated Syndrome with or Without Subsequent MS.

Serum Immunoglobulin G Level and Neutrophils to Lymphocytes Ratio Associated with the Prognosis of Neuromyelitis Optica Spectrum Disorder.

Lesion Activity on Brain MRI in a Chinese Population with Unilateral Optic Neuritis

A-100 Selected pro-and anti-inflammatory cytokine serum concentrations in different clinical forms of multiple sclerosis

Serum Levels of Interleukin (IL)-18, IL-23 and IL-17 in Chinese Patients with Multiple Sclerosis

Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions

Cerebrospinal Fluid Oligoclonal Bands in Chinese Patients with Multiple Sclerosis: the Prevalence and Its Association with Clinical Features

Progressive Brain Rich-Club Network Disruption from Clinically Isolated Syndrome Towards Multiple Sclerosis

Concentrations of Vascular Endothelial Growth Factor in Serum and Cerebrospinal Fluid of Patients with Clinically Isolated Syndrome

Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis

Cerebrospinal Fluid Chloride is Associated with Disease Activity of Relapsing–Remitting Multiple Sclerosis: A Retrospective Cohort Study

Functional Brain Network Alterations in Clinically Isolated Syndrome and Multiple Sclerosis: A Graph-based Connectome Study.

Spinal Clinically Isolated Syndromes:Clinical and MRI Analysis